Zhang, M., Wang, S., Wilffert, B., Tong, R., Soolingen, D., Hof, S., & Alffenaar, J. (2018). The association between the NAT2 genetic polymorphisms and risk of DILI during anti‐TB treatment: A systematic review and meta‐analysis. British journal of clinical pharmacology, 84(12), 2747-2760. https://doi.org/10.1111/bcp.13722
Citace podle Chicago (17th ed.)Zhang, Min, Shuqiang Wang, Bob Wilffert, Rongsheng Tong, Dick Soolingen, Susan Hof, a Jan‐Willem Alffenaar. "The Association Between the NAT2 Genetic Polymorphisms and Risk of DILI During Anti‐TB Treatment: A Systematic Review and Meta‐analysis." British Journal of Clinical Pharmacology 84, no. 12 (2018): 2747-2760. https://doi.org/10.1111/bcp.13722.
Citace podle MLA (9th ed.)Zhang, Min, et al. "The Association Between the NAT2 Genetic Polymorphisms and Risk of DILI During Anti‐TB Treatment: A Systematic Review and Meta‐analysis." British Journal of Clinical Pharmacology, vol. 84, no. 12, 2018, pp. 2747-2760, https://doi.org/10.1111/bcp.13722.